Genomics Market - Forecast(2025 - 2031)

Report Code: HCR 0027 Report Format: PDF + Excel

Genomics Market Overview:

Genomics Market Size is valued at $104.9 Billion by 2030, and is anticipated to grow at a CAGR of 12.4% during the forecast period 2024 -2030. The genomics market focuses on the study of genes, their functions, and interactions, leveraging technologies like sequencing and bioinformatics. Its applications span precision medicine, diagnostics, agricultural genomics, and drug discovery. 
Key trends include advancements in Next-Generation Sequencing (NGS), CRISPR-based gene editing, and population-wide genomic initiatives. The increasing demand for personalized healthcare solutions and agricultural sustainability has expanded its global reach. With growing government investments and collaborations between research institutions and industries, the genomics market is rapidly evolving. By integrating artificial intelligence and big data analytics, the sector is set to revolutionize healthcare, agriculture, and biotechnology, making genomics a cornerstone of modern science.

Market Snapshot: 

Genomics Market - Report Coverage:

The “Genomics Market Report - Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Genomics Market.

Attribute

Segment

By Product Type

  • Instruments
    • Microarray Chips
    • DNA Sequencers
    • Thermal Cyclers
    • Electrophoresis Equipment
    • Mass Spectrometers
    • Others
  • Reagents and Consumables

 

 

 

By Service Type

  • Bioinformatics Services
    • Bioinformatics Databases
    • Bioinformatics Tools
  • Laboratory Services
    • DNA Sample Sequencing
    • De Novo Sequencing
    • Targeted Re-Sequencing
    • Individual Genome Sequencing
    • SNP Analysis
    • Molecular Biology
    • Gene Expression Analysis
    • Biomarker Solutions
    • Others

 

By Technique

  • PCR
  • Microarray Analysis
  • Chromatography
  • X-ray Crystallography
  • Electrophoresis
  • Others

 

 

By Application

  • Genotyping
  • Epigenetics
  • Gene Expression and Transcriptome Analysis
  • Cytogenomics
  • Personalized Medicine
  • Proteomics
  • Vaccine Synthesis
  • Synthetic Biology and Bioengineering
  • Drug Discovery
  • Gene Mapping
  • Agrigenomics
  • Others

 

 

By End-User

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CRO)
  • Academic and Research Institutes
  • Healthcare Facilities & Diagnostic Centers
  • Agriculture
  • Others

 

 

 

By Geography

  • North America (USA, Canada, and Mexico)
  • Europe (UK, Germany, France, Italy, Netherlands, Spain, Russia, and Rest of Europe)
  • Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Malaysia, and Rest of APAC)
  • South America (Brazil, Argentina, Colombia, Chile, and Rest of South America)
  • Rest of the World (Middle East, and Africa).

COVID-19 / Ukraine Crisis - Impact Analysis:  

•    The COVID-19 pandemic accelerated the genomics market’s growth, emphasizing its role in disease surveillance and vaccine development. Genomic sequencing was critical for tracking SARS-CoV-2 variants and enabling rapid diagnostics. Investments surged in sequencing technologies, as governments and institutions prioritized pandemic preparedness. Demand for portable sequencing devices and genomic data-sharing platforms increased, driving innovation. However, research on non-COVID applications faced delays due to resource reallocation. This dual effect highlighted genomics’ potential to address future public health crises. The pandemic reshaped the genomics landscape, catalyzing its adoption across healthcare, diagnostics, and pharmaceutical sectors, ensuring sustained market momentum post-COVID-19.

•    The Russia-Ukraine war disrupted the genomics market, primarily through supply chain interruptions and reduced funding in affected regions. Essential laboratory equipment and reagents faced delays, hampering research progress. Geopolitical instability diverted governmental priorities from genomics investments to immediate economic and defense concerns. Additionally, partnerships with regional research institutions experienced setbacks, slowing innovation. On a broader scale, the conflict emphasized the need for diversified supply chains and collaboration strategies. While the war created temporary challenges, global markets are adapting to mitigate risks and ensure the continuity of genomic research, which remains essential for healthcare and agricultural advancements globally.

Key Takeaways:

•    Polymerase Chain Reaction (PCR) Segment Recorded the Highest Growth in the Genomics Market

Polymerase Chain Reaction (PCR) is the fastest-growing technique in the genomics market, fueled by its versatility, cost-effectiveness, and precision in amplifying DNA sequences. Its critical role in diagnostics, particularly in detecting genetic mutations and pathogens, has seen a significant rise post-COVID-19, with its use in viral testing showcasing its scalability. In research, PCR is indispensable for gene expression analysis, genotyping, and DNA cloning, driving its widespread adoption across pharmaceutical, biotechnology, and academic institutions. Recent advancements, such as digital PCR, have enhanced sensitivity and quantification accuracy, making the technique even more attractive. Moreover, its integration into portable devices has opened doors for point-of-care testing, expanding accessibility in low-resource settings. The global focus on personalized medicine and molecular diagnostics further supports its growth. As PCR continues to evolve with technological improvements, it is poised to remain a cornerstone of genomic studies and diagnostics, making it the fastest-growing genomics technique.

•    Dominance Pharmaceutical and Biotechnology Companies Segment in the Genomics Market

In 2023, pharmaceutical and biotechnology companies dominate the genomics market, driven by their extensive adoption of genomic technologies in drug discovery, precision medicine, and biologics development. These companies leverage genomics to identify therapeutic targets, optimize drug efficacy, and reduce the time-to-market for innovative treatments. The rising demand for gene therapies and personalized medicine has further spurred investment in advanced sequencing technologies and genomic data analysis. Additionally, collaborations between pharmaceutical giants and genomic solution providers, such as Illumina and Thermo Fisher Scientific, have accelerated market growth by enabling large-scale genomic studies. With regulatory bodies like the FDA emphasizing genomic-based drug approvals, these companies are increasingly integrating genomics into their R&D pipelines. The ability to address critical healthcare challenges, including cancer, rare diseases, and infectious diseases, positions pharmaceutical and biotechnology firms as key contributors to the market's expansion. Their role is pivotal in maintaining dominance within the genomics industry.

•    Rising Demand for Genomics Driven by the Growing Need for Precision Medicine

The emphasis on precision medicine is a major driver in the genomics market, utilizing genomic data to create tailored treatments based on individual genetic profiles, which enhances patient outcomes. Notably, genomics-based cancer therapies, such as PARP inhibitors, have transformed oncology by targeting specific genetic mutations. According to the Personalized Medicine Coalition (PMC), personalized medicines made up over one-third of new U.S. Food and Drug Administration (FDA) drug approvals in 2023, highlighting the increasing influence of genomics in drug development and healthcare. Additionally, technological advancements in sequencing, particularly Next-Generation Sequencing (NGS), have significantly lowered costs, making genomic insights more accessible for clinical applications. As healthcare systems around the globe increasingly adopt personalized treatment strategies, the genomics market is witnessing robust growth. This expansion is largely fueled by the escalating demand for genomic applications within oncology, cardiology, and rare genetic disorders, reflecting an ongoing shift toward individualized medicine.

•    Negative Impact of Ethical and Regulatory Concerns on the Genomics Market

The genomics market encounters significant ethical and regulatory challenges that can impede its growth. Key concerns include data privacy, informed consent, and genetic discrimination, particularly in regions with inadequate regulatory frameworks. Unauthorized use of genetic data poses threats to patient confidentiality, while the absence of standardized regulations complicates the approval process for genomics-based diagnostics and therapies. Ethical dilemmas associated with technologies like CRISPR further hinder progress, as potential misuse for non-therapeutic purposes raises public apprehension. Nevertheless, regulations such as the Common Rule and HIPAA in the U.S. strive to balance scientific advancement with the protection of patient privacy, laying the groundwork for responsible genomic research and clinical applications. To foster public trust and ensure that genomic innovations align with societal expectations, it is crucial to address these ethical and regulatory challenges. This approach will ultimately support the continued growth and acceptance of genomic technologies in healthcare and beyond.
 
Key Market Players: 

Product launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Genomics Market. The top 10 companies in this industry are listed below:
1.    Thermo Fisher Scientific Inc.
2.    Illumina, Inc.
3.    F. Hoffmann-La Roche Ltd
4.    Qiagen N.V.
5.    Agilent Technologies Inc.
6.    Myriad Genetics Inc.
7.    Pacific Biosciences of California, Inc.
8.    Bio-Rad Laboratories
9.    PerkinElmer Inc.
10.    Luminex Corporation

Scope of the Report: 

Report Metric

Details

Base Year Considered

2023

Forecast Period

2024-2030

CAGR

12.4%

Market Size in 2030

$ 104.9 billion

Segments Covered

By Product Type, By Service Type, By Technique, By Application, By End-user, and By Region

Regions Covered

North America (USA, Canada, and Mexico), Europe (UK, Germany, France, Italy, Netherlands, Spain, Russia, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Malaysia, and Rest of APAC), South America (Brazil, Argentina, Colombia, Chile, and Rest of South America), and Rest of the World (Middle East, and Africa).

Key Market Players

  1. Thermo Fisher Scientific Inc.
  2. Illumina, Inc.
  3. F. Hoffmann-La Roche Ltd
  4. Qiagen N.V.
  5. Agilent Technologies Inc.
  6. Myriad Genetics Inc.
  7. Pacific Biosciences of California, Inc.
  8. Bio-Rad Laboratories
  9. PerkinElmer Inc.
  10. Luminex Corporation

For More Lifesciences and Healthcare Market Reports - Please Click Here

1. Genomics Market- Market Overview
    1.1 Definitions and Scope
2. Genomics Market - Executive Summary
    2.1 Key Trends by Product Type
    2.2 Key Trends by Service Type
    2.3 Key Trends by Technique
    2.4 Key Trends by Application
    2.5 Key Trends by End-User
    2.6 Key Trends Segmented by Geography
3. Genomics Market – Comparative Analysis 
    3.1 Market Share Analysis - Major Companies
    3.2 Product Benchmarking - Major Companies
    3.3 Top 5 Financials Analysis
    3.4 Patent Analysis - Major Companies
    3.5 Pricing Analysis (ASPs will be provided)
4. Genomics Market– Startup Companies Scenario
    4.1 Major startup company analysis:
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Product portfolio
        4.1.4 Venture Capital and Funding Scenario
5. Genomics Market– Industry Market Entry Scenario Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Successful Venture Profiles
    5.4 Customer Analysis – Major companies
6. Genomics Market- Market Forces
    6.1 Market Drivers
    6.2 Market Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Genomics Market– By Strategic Analysis (Market Size -$Million/Billion)
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis 
    7.3 Product Life Cycle
    7.4 Suppliers and Distributors
8. Genomics Market- By Product Type (Market Size -$Million/Billion)
    8.1 Instruments
        8.1.1 Microarray Chips
        8.1.2 DNA Sequencers
        8.1.3 Thermal Cyclers
        8.1.4 Electrophoresis Equipment
        8.1.5 Mass Spectrometers
        8.1.6 Others
    8.2 Reagents and Consumables
9. Genomics Market- By Service Type (Market Size -$Million/Billion)
    9.1 Bioinformatics Services
        9.1.1 Bioinformatics Databases
        9.1.2 Bioinformatics Tools
    9.2 Laboratory Services
        9.2.1 DNA Sample Sequencing
        9.2.2 De Novo Sequencing
        9.2.3 Targeted Re-Sequencing
        9.2.4 Individual Genome Sequencing
        9.2.5 SNP Analysis
        9.2.6 Molecular Biology
        9.2.7 Gene Expression Analysis
        9.2.8 Biomarker Solutions
        9.2.9 Others
10. Genomics Market- By Technique (Market Size -$Million/Billion)
    10.1 PCR
    10.2 Microarray Analysis
    10.3 Chromatography
    10.4 X-ray Crystallography
    10.5 Electrophoresis
    10.6 Others
11. Genomics Market- By Application (Market Size -$Million/Billion)
    11.1 Genotyping
    11.2 Epigenetics
    11.3 Gene Expression and Transcriptome Analysis
    11.4 Cytogenomics
    11.5 Personalized Medicine
    11.6 Proteomics
    11.7 Vaccine Synthesis
    11.8 Synthetic Biology and Bioengineering
    11.9 Drug Discovery
    11.10 Gene Mapping
    11.11 Agrigenomics
    11.12 Others
12. Genomics Market- By End-User (Market Size -$Million/Billion)
    12.1 Pharmaceutical and Biotechnology Companies
    12.2 Contract Research Organizations (CRO)
    12.3 Academic and Research Institutes
    12.4 Healthcare Facilities & Diagnostic Centers
    12.5 Agriculture
    12.6 Others
13. Genomics Market- By Geography (Market Size -$Million/Billion)
    13.1 North America
        13.1.1 USA
        13.1.2 Canada
        13.1.3 Mexico
    13.2 South America
        13.2.1 Brazil
        13.2.2 Argentina
        13.2.3 Colombia
        13.2.4 Chile
        13.2.5 Rest of South America
    13.3 Europe
        13.3.1 UK
        13.3.2 Germany
        13.3.3 France
        13.3.4 Italy
        13.3.5 Netherlands
        13.3.6 Spain
        13.3.7 Russia
        13.3.8 Rest of Europe
    13.4 Asia-Pacific
        13.4.1 China
        13.4.2 Japan
        13.4.3 India
        13.4.4 South Korea
        13.4.5 Australia
        13.4.6 Indonesia
        13.4.7 Malaysia
        13.4.8 Rest of APAC
    13.5 Rest of the World
        13.5.1 Middle East
        13.5.2 Africa
14. Genomics Market- Entropy
    14.1 New Product Launches
    14.2 M&As, Collaborations, JVs and Partnerships
15. Genomics Market- Industry Competition Landscape
    15.1 Market Share at Global Level - Major companies
    15.2 Market Share by Key Region - Major companies
    15.3 Market Share by Key Country - Major companies
    15.4 Market Share by Key Applications - Major companies
16. Genomics Market – Key Company List by Country Premium 
17. Genomics Market Company Analysis (Market Overview, Product Portfolio, Revenue, Developments)

    17.1 Thermo Fisher Scientific Inc.
    17.2 Illumina, Inc.
    17.3 F. Hoffmann-La Roche Ltd
    17.4 Qiagen N.V.
    17.5 Agilent Technologies Inc.
    17.6 Myriad Genetics Inc.
    17.7 Pacific Biosciences of California, Inc.
    17.8 Bio-Rad Laboratories
    17.9 PerkinElmer Inc.
    17.10 Luminex Corporation.
 

List of Tables

Table 1: Genomics Market Overview 2023-2030
Table 2: Genomics Market Leader Analysis 2023-2024 (US$)
Table 3: Genomics Market Product Analysis 2023-2024 (US$)
Table 4: Genomics Market End User Analysis 2023-2024 (US$)
Table 5: Genomics Market Patent Analysis 2021-2023* (US$)
Table 6: Genomics Market Financial Analysis 2023-2024 (US$)
Table 7: Genomics Market Driver Analysis 2023-2024 (US$)
Table 8: Genomics Market Challenges Analysis 2023-2024 (US$)
Table 9: Genomics Market Constraint Analysis 2023-2024 (US$)
Table 10: Genomics Market Supplier Bargaining Power Analysis 2023-2024 (US$)
Table 11: Genomics Market Buyer Bargaining Power Analysis 2023-2024 (US$)
Table 12: Genomics Market Threat of Substitutes Analysis 2023-2024 (US$)
Table 13: Genomics Market Threat of New Entrants Analysis 2023-2024 (US$)
Table 14: Genomics Market Degree of Competition Analysis 2023-2024 (US$)
Table 15: Genomics Market Value Chain Analysis 2023-2024 (US$)
Table 16: Genomics Market Pricing Analysis 2023-2030 (US$)
Table 17: Genomics Market Opportunities Analysis 2023-2030 (US$)
Table 18: Genomics Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19: Genomics Market Supplier Analysis 2023-2024 (US$)
Table 20: Genomics Market Distributor Analysis 2023-2024 (US$)
Table 21: Genomics Market Trend Analysis 2023-2024 (US$)
Table 22: Genomics Market Size 2023 (US$)
Table 23: Genomics Market Forecast Analysis 2023-2030 (US$)
Table 24: Genomics Market Sales Forecast Analysis 2023-2030 (Units)
Table 25: Genomics Market, Revenue & Volume, By Product Type, 2023-2030 ($)
Table 26: Genomics Market By Product Type, Revenue & Volume, By Introduction, 2023-2030 ($)
Table 27: Genomics Market By Product Type, Revenue & Volume, By Products, 2023-2030 ($)
Table 28: Genomics Market By Product Type, Revenue & Volume, By DNA Microarrays, 2023-2030 ($)
Table 29: Genomics Market By Product Type, Revenue & Volume, By Electrophoresis, 2023-2030 ($)
Table 30: Genomics Market By Product Type, Revenue & Volume, By X-Ray Crystallography, 2023-2030 ($)
Table 31: Genomics Market, Revenue & Volume, By Service Industry Analysis, 2023-2030 ($)
Table 32: Genomics Market By Service Industry Analysis, Revenue & Volume, By Introduction, 2023-2030 ($)
Table 33: Genomics Market By Service Industry Analysis, Revenue & Volume, By Bio-Informatics Database, 2023-2030 ($)
Table 34: Genomics Market By Service Industry Analysis, Revenue & Volume, By Bio-Informatics Tools, 2023-2030 ($)
Table 35: Genomics Market By Service Industry Analysis, Revenue & Volume, By Laboratory Services, 2023-2030 ($)
Table 36: Genomics Market By Service Industry Analysis, Revenue & Volume, By DNA Sample Sequencing, 2023-2030 ($)
Table 37: Genomics Market, Revenue & Volume, By End User Application, 2023-2030 ($)
Table 38: Genomics Market By End User Application, Revenue & Volume, By Introduction, 2023-2030 ($)
Table 39: Genomics Market By End User Application, Revenue & Volume, By Anthropology, 2023-2030 ($)
Table 40: Genomics Market By End User Application, Revenue & Volume, By Agriculture, 2023-2030 ($)
Table 41: Genomics Market By End User Application, Revenue & Volume, By Cytogenetics, 2023-2030 ($)
Table 42: Genomics Market By End User Application, Revenue & Volume, By Diagnostics, 2023-2030 ($)
Table 43: North America Genomics Market, Revenue & Volume, By Product Type, 2023-2030 ($)
Table 44: North America Genomics Market, Revenue & Volume, By Service Industry Analysis, 2023-2030 ($)
Table 45: North America Genomics Market, Revenue & Volume, By End User Application, 2023-2030 ($)
Table 46: South america Genomics Market, Revenue & Volume, By Product Type, 2023-2030 ($)
Table 47: South america Genomics Market, Revenue & Volume, By Service Industry Analysis, 2023-2030 ($)
Table 48: South america Genomics Market, Revenue & Volume, By End User Application, 2023-2030 ($)
Table 49: Europe Genomics Market, Revenue & Volume, By Product Type, 2023-2030 ($)
Table 50: Europe Genomics Market, Revenue & Volume, By Service Industry Analysis, 2023-2030 ($)
Table 51: Europe Genomics Market, Revenue & Volume, By End User Application, 2023-2030 ($)
Table 52: APAC Genomics Market, Revenue & Volume, By Product Type, 2023-2030 ($)
Table 53: APAC Genomics Market, Revenue & Volume, By Service Industry Analysis, 2023-2030 ($)
Table 54: APAC Genomics Market, Revenue & Volume, By End User Application, 2023-2030 ($)
Table 55: Middle East & Africa Genomics Market, Revenue & Volume, By Product Type, 2023-2030 ($)
Table 56: Middle East & Africa Genomics Market, Revenue & Volume, By Service Industry Analysis, 2023-2030 ($)
Table 57: Middle East & Africa Genomics Market, Revenue & Volume, By End User Application, 2023-2030 ($)
Table 58: Russia Genomics Market, Revenue & Volume, By Product Type, 2023-2030 ($)
Table 59: Russia Genomics Market, Revenue & Volume, By Service Industry Analysis, 2023-2030 ($)
Table 60: Russia Genomics Market, Revenue & Volume, By End User Application, 2023-2030 ($)
Table 61: Israel Genomics Market, Revenue & Volume, By Product Type, 2023-2030 ($)
Table 62: Israel Genomics Market, Revenue & Volume, By Service Industry Analysis, 2023-2030 ($)
Table 63: Israel Genomics Market, Revenue & Volume, By End User Application, 2023-2030 ($)
Table 64: Top Companies 2023 (US$)Genomics Market, Revenue & Volume
Table 65: Product Launch 2023-2024Genomics Market, Revenue & Volume
Table 66: Mergers & Acquistions 2023-2024Genomics Market, Revenue & Volume

List of Figures

Figure 1: Overview of Genomics Market 2023-2030
Figure 2: Market Share Analysis for Genomics Market 2023 (US$)
Figure 3: Product Comparison in Genomics Market 2023-2024 (US$)
Figure 4: End User Profile for Genomics Market 2023-2024 (US$)
Figure 5: Patent Application and Grant in Genomics Market 2021-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Genomics Market 2023-2024 (US$)
Figure 7: Market Entry Strategy in Genomics Market 2023-2024
Figure 8: Ecosystem Analysis in Genomics Market 2023
Figure 9: Average Selling Price in Genomics Market 2023-2030
Figure 10: Top Opportunites in Genomics Market 2023-2024
Figure 11: Market Life Cycle Analysis in Genomics Market
Figure 12: GlobalBy Product TypeGenomics Market Revenue, 2023-2030 ($)
Figure 13: GlobalBy Service Industry AnalysisGenomics Market Revenue, 2023-2030 ($)
Figure 14: GlobalBy End User ApplicationGenomics Market Revenue, 2023-2030 ($)
Figure 15: Global Genomics Market - By Geography
Figure 16: Global Genomics Market Value & Volume, By Geography, 2023-2030 ($) 
Figure 17: Global Genomics Market CAGR, By Geography, 2023-2030 (%)
Figure 18: North America Genomics Market Value & Volume, 2023-2030 ($)
Figure 19: US Genomics Market Value & Volume, 2023-2030 ($)
Figure 20: US GDP and Population, 2023-2024 ($)
Figure 21: US GDP – Composition of 2023, By Sector of Origin
Figure 22: US Export and Import Value & Volume, 2023-2024 ($)
Figure 23: Canada Genomics Market Value & Volume, 2023-2030 ($)
Figure 24: Canada GDP and Population, 2023-2024 ($)
Figure 25: Canada GDP – Composition of 2023, By Sector of Origin
Figure 26: Canada Export and Import Value & Volume, 2023-2024 ($)
Figure 27: Mexico Genomics Market Value & Volume, 2023-2030 ($)
Figure 28: Mexico GDP and Population, 2023-2024 ($)
Figure 29: Mexico GDP – Composition of 2023, By Sector of Origin
Figure 30: Mexico Export and Import Value & Volume, 2023-2024 ($)
Figure 31: South America Genomics Market Value & Volume, 2023-2030 ($)
Figure 32: Brazil Genomics Market Value & Volume, 2023-2030 ($)
Figure 33: Brazil GDP and Population, 2023-2024 ($)
Figure 34: Brazil GDP – Composition of 2023, By Sector of Origin
Figure 35: Brazil Export and Import Value & Volume, 2023-2024 ($)
Figure 36: Venezuela Genomics Market Value & Volume, 2023-2030 ($)
Figure 37: Venezuela GDP and Population, 2023-2024 ($)
Figure 38: Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 39: Venezuela Export and Import Value & Volume, 2023-2024 ($)
Figure 40: Argentina Genomics Market Value & Volume, 2023-2030 ($)
Figure 41: Argentina GDP and Population, 2023-2024 ($)
Figure 42: Argentina GDP – Composition of 2023, By Sector of Origin
Figure 43: Argentina Export and Import Value & Volume, 2023-2024 ($)
Figure 44: Ecuador Genomics Market Value & Volume, 2023-2030 ($)
Figure 45: Ecuador GDP and Population, 2023-2024 ($)
Figure 46: Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 47: Ecuador Export and Import Value & Volume, 2023-2024 ($)
Figure 48: Peru Genomics Market Value & Volume, 2023-2030 ($)
Figure 49: Peru GDP and Population, 2023-2024 ($)
Figure 50: Peru GDP – Composition of 2023, By Sector of Origin
Figure 51: Peru Export and Import Value & Volume, 2023-2024 ($)
Figure 52: Colombia Genomics Market Value & Volume, 2023-2030 ($)
Figure 53: Colombia GDP and Population, 2023-2024 ($)
Figure 54: Colombia GDP – Composition of 2023, By Sector of Origin
Figure 55: Colombia Export and Import Value & Volume, 2023-2024 ($)
Figure 56: Costa Rica Genomics Market Value & Volume, 2023-2030 ($)
Figure 57: Costa Rica GDP and Population, 2023-2024 ($)
Figure 58: Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 59: Costa Rica Export and Import Value & Volume, 2023-2024 ($)
Figure 60: Europe Genomics Market Value & Volume, 2023-2030 ($)
Figure 61: U.K Genomics Market Value & Volume, 2023-2030 ($)
Figure 62: U.K GDP and Population, 2023-2024 ($)
Figure 63: U.K GDP – Composition of 2023, By Sector of Origin
Figure 64: U.K Export and Import Value & Volume, 2023-2024 ($)
Figure 65: Germany Genomics Market Value & Volume, 2023-2030 ($)
Figure 66: Germany GDP and Population, 2023-2024 ($)
Figure 67: Germany GDP – Composition of 2023, By Sector of Origin
Figure 68: Germany Export and Import Value & Volume, 2023-2024 ($)
Figure 69: Italy Genomics Market Value & Volume, 2023-2030 ($)
Figure 70: Italy GDP and Population, 2023-2024 ($)
Figure 71: Italy GDP – Composition of 2023, By Sector of Origin
Figure 72: Italy Export and Import Value & Volume, 2023-2024 ($)
Figure 73: France Genomics Market Value & Volume, 2023-2030 ($)
Figure 74: France GDP and Population, 2023-2024 ($)
Figure 75: France GDP – Composition of 2023, By Sector of Origin
Figure 76: France Export and Import Value & Volume, 2023-2024 ($)
Figure 77: Netherlands Genomics Market Value & Volume, 2023-2030 ($)
Figure 78: Netherlands GDP and Population, 2023-2024 ($)
Figure 79: Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 80: Netherlands Export and Import Value & Volume, 2023-2024 ($)
Figure 81: Belgium Genomics Market Value & Volume, 2023-2030 ($)
Figure 82: Belgium GDP and Population, 2023-2024 ($)
Figure 83: Belgium GDP – Composition of 2023, By Sector of Origin
Figure 84: Belgium Export and Import Value & Volume, 2023-2024 ($)
Figure 85: Spain Genomics Market Value & Volume, 2023-2030 ($)
Figure 86: Spain GDP and Population, 2023-2024 ($)
Figure 87: Spain GDP – Composition of 2023, By Sector of Origin
Figure 88: Spain Export and Import Value & Volume, 2023-2024 ($)
Figure 89: Denmark Genomics Market Value & Volume, 2023-2030 ($)
Figure 90: Denmark GDP and Population, 2023-2024 ($)
Figure 91: Denmark GDP – Composition of 2023, By Sector of Origin
Figure 92: Denmark Export and Import Value & Volume, 2023-2024 ($)
Figure 93: APAC Genomics Market Value & Volume, 2023-2030 ($)
Figure 94: China Genomics Market Value & Volume, 2023-2030
Figure 95: China GDP and Population, 2023-2024 ($)
Figure 96: China GDP – Composition of 2023, By Sector of Origin
Figure 97: China Export and Import Value & Volume, 2023-2024 ($)Genomics Market China Export and Import Value & Volume, 2023-2024 ($)
Figure 98: Australia Genomics Market Value & Volume, 2023-2030 ($)
Figure 99: Australia GDP and Population, 2023-2024 ($)
Figure 100: Australia GDP – Composition of 2023, By Sector of Origin
Figure 101: Australia Export and Import Value & Volume, 2023-2024 ($)
Figure 102: South Korea Genomics Market Value & Volume, 2023-2030 ($)
Figure 103: South Korea GDP and Population, 2023-2024 ($)
Figure 104: South Korea GDP – Composition of 2023, By Sector of Origin
Figure 105: South Korea Export and Import Value & Volume, 2023-2024 ($)
Figure 106: India Genomics Market Value & Volume, 2023-2030 ($)
Figure 107: India GDP and Population, 2023-2024 ($)
Figure 108: India GDP – Composition of 2023, By Sector of Origin
Figure 109: India Export and Import Value & Volume, 2023-2024 ($)
Figure 110: Taiwan Genomics Market Value & Volume, 2023-2030 ($)
Figure 111: Taiwan GDP and Population, 2023-2024 ($)
Figure 112: Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 113: Taiwan Export and Import Value & Volume, 2023-2024 ($)
Figure 114: Malaysia Genomics Market Value & Volume, 2023-2030 ($)
Figure 115: Malaysia GDP and Population, 2023-2024 ($)
Figure 116: Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 117: Malaysia Export and Import Value & Volume, 2023-2024 ($)
Figure 118: Hong Kong Genomics Market Value & Volume, 2023-2030 ($)
Figure 119: Hong Kong GDP and Population, 2023-2024 ($)
Figure 120: Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 121: Hong Kong Export and Import Value & Volume, 2023-2024 ($)
Figure 122: Middle East & Africa Genomics Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 123: Russia Genomics Market Value & Volume, 2023-2030 ($)
Figure 124: Russia GDP and Population, 2023-2024 ($)
Figure 125: Russia GDP – Composition of 2023, By Sector of Origin
Figure 126: Russia Export and Import Value & Volume, 2023-2024 ($)
Figure 127: Israel Genomics Market Value & Volume, 2023-2030 ($)
Figure 128: Israel GDP and Population, 2023-2024 ($)
Figure 129: Israel GDP – Composition of 2023, By Sector of Origin
Figure 130: Israel Export and Import Value & Volume, 2023-2024 ($)
Figure 131: Entropy Share, By Strategies, 2023-2024* (%)Genomics Market
Figure 132: Developments, 2023-2024*Genomics Market
Figure 133: Company 1 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 134: Company 1 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 135: Company 1 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 136: Company 2 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 137: Company 2 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 138: Company 2 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 139: Company 3 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 140: Company 3 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 141: Company 3 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 142: Company 4 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 143: Company 4 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 144: Company 4 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 145: Company 5 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 146: Company 5 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 147: Company 5 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 148: Company 6 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 149: Company 6 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 150: Company 6 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 151: Company 7 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 152: Company 7 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 153: Company 7 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 154: Company 8 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 155: Company 8 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 156: Company 8 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 157: Company 9 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 158: Company 9 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 159: Company 9 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 160: Company 10 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 161: Company 10 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 162: Company 10 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 163: Company 11 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 164: Company 11 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 165: Company 11 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 166: Company 12 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 167: Company 12 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 168: Company 12 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 169: Company 13 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 170: Company 13 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 171: Company 13 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 172: Company 14 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 173: Company 14 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 174: Company 14 Genomics Market Net Sales Share, By Geography, 2023 (%)
Figure 175: Company 15 Genomics Market Net Revenue, By Years, 2023-2024* ($)
Figure 176: Company 15 Genomics Market Net Revenue Share, By Business segments, 2023 (%)
Figure 177: Company 15 Genomics Market Net Sales Share, By Geography, 2023 (%)

The Genomics Market is projected to grow at 12.4% CAGR during the forecast period 2024-2030.

The Genomics Market size is estimated to surpass $104.9 billion by 2030.

The leading players in the Genomics Market are Thermo Fisher Scientific Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd, Qiagen N.V., Agilent Technologies Inc., and others.